insights_auto
Why is GIS up ၂.၅၇%?
Dive Deeperchevron_right
GIS:ETR
Gilead Sciences, Inc
၁၃၆.၃၂ €
arrow_upward
+၂.၅၇%(+၃.၄၂) 1D
အောက် ၁၄, GMT+၂ ၁၇:၃၅:၃၁ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIS...
Open
၁၃၁.၈၆ €
High
၁၃၆.၄၈ €
Low
၁၃၁.၇၈ €
Mkt. cap
ဋေ ၁.၉၀ သ
Avg. vol.
၈၀၅.၀၀
Volume
၃၃၁.၀၀
52-wk high
၁၃၆.၄၈ €
52-wk low
၉၈.၉၆ €
No. of employees
၂ သောင်း
Open
၁၃၁.၈၆ €
High
၁၃၆.၄၈ €
Low
၁၃၁.၇၈ €
Mkt. cap
ဋေ ၁.၉၀ သ
Avg. vol.
၈၀၅.၀၀
Volume
၃၃၁.၀၀
52-wk high
၁၃၆.၄၈ €
52-wk low
၉၈.၉၆ €
No. of employees
၂ သောင်း
News stories
From web sources and news partners
Kalkine Media
·
ပြီးခဲ့သည့် ၆ နာရီ
Gilead Sciences (NASDAQ:GILD): What Changes After Its Latest Company Update?
MarketBeat
·
ပြီးခဲ့သည့် ၇ နာရီ
Gilead Sciences (NASDAQ:GILD) Stock Price Up 3.9% - What's Next?
StocksToTrade
·
ပြီးခဲ့သည့် ၈ နာရီ
Gilead Sciences Stock Draws Wave Of Bullish Target Hikes
TradingKey
·
ပြီးခဲ့သည့် ၉ နာရီ
Gilead Sciences Inc Stock (GILD) Moved Up by 3.12% on Oct 14: Facts Behind the Movement
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About Gilead Sciences, Inc
CEODaniel O'Day
Employees၁.၇ သောင်း
Founded၁၉၈၇ ဇွန် ၂၂
HeadquartersFoster City, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitegilead.com